The global Dementia - Alzheimer’s Disease Market is at a historic crossroads in 2026. After decades of research focused solely on symptomatic relief, the market has officially transitioned into the era of Disease-Modifying Therapies (DMTs). This shift is fundamentally altering the economic landscape of neurology, moving from low-cost generic management to high-value, specialized biolo... https://logcla.com/blogs/947640/Low-Zero-Sugar-Energy-Drinks-Segment-Dominance-and-Revenue-Projection